Rat models of colistin nephrotoxicity: previous experimental researches and future perspectives
- 60 Downloads
Colistin is an old antibiotic, which is abandoned decades ago because of high nephrotoxicity rates. However, it is reintroduced to clinical medicine due to lack of newly discovered antibiotics and is still widely used for the treatment of resistant gram-negative infections. Discovering mechanisms to reduce nephrotoxicity risk is of significant importance since exposed patients may have many other factors that alter kidney functions. Several agents were evaluated in animal models of colistin nephrotoxicity as a means to prevent kidney injury. Considerable heterogeneity exists in terms of reporting colistin dosing and experimental designs. This issue leads clinicians to face difficulties in designing studies and sometimes may lead to report dosing strategies inadequately. Here, we present a review according to animal models of colistin nephrotoxicity using data gathered from previous experiments to draw attention on possible complexities that researchers may encounter.
KeywordsAnimal model Colistin Nephrotoxicity
Conception and Design: CH.
Analysis and interpretation of data: CH, MAO.
Drafting the work or revising it critically for important intellectual content: CH, MAO.
Final approval of the version to be published: CH, MAO, ZÇ.
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
- 1.Tran TB, Velkov T, Nation RL et al (2016) Pharmacokinetics/pharmacodynamics of colistin and polymyxin B: are we there yet? Int J Antimicrob Agents 48:592Google Scholar
- 4.He H, Li JC, Nation RL et al (2013) Pharmacokinetics of four different brands of colistimethate and formed colistin in rats. J Antimicrob Chemother 68(10):2311–2317Google Scholar
- 6.Falagas ME, Kasiakou SK (2006) Use of international units when dosing colistin will help decrease confusion related to various formulations of the drug around the world. Antimicrob Agents Chemother 50(6):2274–2275Google Scholar
- 7.Li J, Nation RL, Turnidge JD (2006) Defining the dosage units for colistin methanesulfonate: urgent need for international harmonization. Antimicrob Agents Chemother 50(12):4231 author reply 4231-2Google Scholar
- 8.Nation RL, Li J, Cars O, Couet W, Dudley MN, Kaye KS, Mouton JW, Paterson DL, Tam VH, Theuretzbacher U, Tsuji BT, Turnidge JD (2014) Consistent global approach on reporting of colistin doses to promote safe and effective use. Clin Infect Dis 58(1):139–141. https://doi.org/10.1093/cid/cit680 Google Scholar
- 9.American Society of Health System Pharmacists. Warning! Dosing confusion with colistimethate for injection. Available at: http://www.ashp.org/DocLibrary/Policy/PatientSafety/NANAlert-Colistimethatesodium.aspx. Accessed 30 December 2018.
- 10.Yun B, Azad MA, Wang J et al (2014) Imaging the distribution of polymyxins in the kidney. J Antimicrob Chemother 70(3):827–829Google Scholar
- 11.Gupta S, Govil D, Kakar PN et al (2009) Colistin and polymyxin B: a re-emergence. Indian J Crit Care Med 13(2):49–53Google Scholar
- 12.Eadon MT, Hack BK, Alexander JJ, Xu C, Dolan ME, Cunningham PN (2013) Cell cycle arrest in a model of colistin nephrotoxicity. Physiol Genomics 45(19):877–888Google Scholar
- 13.Azad MA, Finnin BA, Poudyal A et al (2013) Polymyxin B induces apoptosis in kidney proximal tubular cells. Antimicrob Agents Chemother 57(9):4329–4335Google Scholar
- 14.Ozkan G, Ulusoy S, Orem A et al (2013) How does colistin-induced nephropathy develop and can it be treated? Antimicrob Agents Chemother 57(8):3463–3469Google Scholar
- 15.Ceylan B, Ozansoy M, Kılıç Ü et al (2018) N-acetylcysteine suppresses colistimethate sodium-induced nephrotoxicity via activation of SOD2, eNOS, and MMP3 protein expressions. Ren Fail 40(1):423–434Google Scholar
- 16.Dai C, Li J, Tang S, Li J, Xiao X (2014) Colistin-induced nephrotoxicity in mice involves the mitochondrial, death receptor, and endoplasmic reticulum pathways. Antimicrob Agents Chemother 58(7):4075–4085Google Scholar
- 17.Dai C, Tang S, Deng S et al (2014) Lycopene attenuates colistin-induced nephrotoxicity in mice via activation of the Nrf2/HO-1 pathway. Antimicrob Agents Chemother 59(1):579–585Google Scholar
- 18.Dai C, Tang S, Wang Y, Velkov T, Xiao X (2017) Baicalein acts as a nephroprotectant that ameliorates colistin-induced nephrotoxicity by activating the antioxidant defence mechanism of the kidneys and down-regulating the inflammatory response. J Antimicrob Chemother 72(9):2562–2569Google Scholar
- 20.Hori Y, Aoki N, Kuwahara S et al (2017) Megalin blockade with cilastatin suppresses drug-induced nephrotoxicity. J Am Soc Nephrol 28(6):1783–1791Google Scholar
- 21.Suzuki T, Yamaguchi H, Ogura J, Kobayashi M, Yamada T, Iseki K (2013) Megalin contributes to kidney accumulation and nephrotoxicity of colistin. Antimicrob Agents Chemother 57(12):6319–6324Google Scholar
- 22.Heidari R, Behnamrad S, Khodami Z, Ommati MM, Azarpira N, Vazin A (2019) The nephroprotective properties of taurine in colistin-treated mice is mediated through the regulation of mitochondrial function and mitigation of oxidative stress. Biomed Pharmacother 109:103–111. https://doi.org/10.1016/j.biopha.2018.10.093 Google Scholar
- 28.Ghlissi Z, Hakim A, Sila A, Mnif H, Zeghal K, Rebai T, Bougatef A, Sahnoun Z (2014) Evaluation of efficacy of natural astaxanthin and vitamin E in prevention of colistin-induced nephrotoxicity in the rat model. Environ Toxicol Pharmacol 37(3):960–966. https://doi.org/10.1016/j.etap.2014.03.004 Google Scholar
- 30.Edrees NE, Galal AAA, Abdel Monaem AR, Beheiry RR, Metwally MMM (2018) Curcumin alleviates colistin-induced nephrotoxicity and neurotoxicity in rats via attenuation of oxidative stress, inflammation and apoptosis. Chem Biol Interact 294:56–64. https://doi.org/10.1016/j.cbi.2018.08.012 Google Scholar
- 32.Yousef JM, Chen G, Hill PA, Nation RL, Li J (2011) Melatonin attenuates colistin-induced nephrotoxicity in rats. Antimicrob Agents Chemother 55(9):4044–4049Google Scholar
- 33.Yousef JM, Chen G, Hill PA, Nation RL, Li J (2011) Ascorbic acid protects against the nephrotoxicity and apoptosis caused by colistin and affects its pharmacokinetics. J Antimicrob Chemother 67(2):452–459Google Scholar
- 35.Hackbarth H, Büttner D, Jarck D, Pothmann M, Messow C, Gärtner K (1983) Distribution of glomeruli in the renal cortex of Munich Wistar Frömter (MWF) rats. Ren Physiol 6(2):63–71Google Scholar
- 36.Wei Q, Wang MH, Dong Z (2005) Differential gender differences in ischemic and nephrotoxic acute renal failure. Am J Nephrol 25:491–499Google Scholar
- 37.Turner PV, Brabb T, Pekow C, Vasbinder MA (2011) Administration of substances to laboratory animals: routes of administration and factors to consider. J Am Assoc Lab Anim Sci 50(5):600–613Google Scholar
- 39.Lewis RE, Kunz AL, Bell RE (1966) Error of intraperitoneal injections in rats. Lab Anim Care 16:505–509Google Scholar
- 40.Keirstead ND, Wagoner MP, Bentley P, Blais M, Brown C, Cheatham L, Ciaccio P, Dragan Y, Ferguson D, Fikes J, Galvin M, Gupta A, Hale M, Johnson N, Luo W, McGrath F, Pietras M, Price S, Sathe AG, Sasaki JC, Snow D, Walsky RL, Kern G (2014) Early prediction of polymyxin-induced nephrotoxicity with next-generation urinary kidney injury biomarkers. Toxicol Sci 137(2):278–291. https://doi.org/10.1093/toxsci/kft247 Google Scholar
- 41.Morton DB, Jennings M, Buckwell A, Ewbank R, Godfrey C, Holgate B, Inglis I, James R, Page C, Sharman I, Verschoyle R, Westall L, Wilson AB, Joint Working Group on Refinement (2001) Refining procedures for the administration of substances. Report of the BVAAWF/FRAME/RSPCA/UFAW Joint Working Group on Refinement. British Veterinary Association Animal Welfare Foundation/Fund for the Replacement of Animals in Medical Experiments/Royal Society for the Prevention of Cruelty to Animals/Universities Federation for Animal Welfare. Lab Anim 35:1–41Google Scholar
- 43.Falagas ME, Fragoulis KN, Kasiakou SK, Sermaidis GJ, Michalopoulos A (2005) Nephrotoxicity of intravenous colistin: a prospective evaluation. Int J Antimicrob Agents 26(6):504–507Google Scholar
- 46.Hakim A, Kallel H, Sahnoun Z, Badraoui R, Jammoussi K, Bouaziz M, Zeghal KM, Rebaii T (2008) Lack of nephrotoxicity following 15-day therapy with high doses of colistin in rats. Med Sci Monit 14(4):BR74–BR77Google Scholar
- 48.Zager RA, Vijayan A, Johnson AC (2012) Proximal tubule haptoglobin gene activation is an integral component of the acute kidney injury “stress response”. Am J Physiol Renal Physiol 303:F139–F148Google Scholar
- 50.de Caestecker M, Humphreys BD, Liu KD et al (2015) Bridging translation by improving preclinical study design in AKI. J Am Soc Nephrol 26(12):2905–2916Google Scholar